Current Issues in Atopic Comorbidities and Preventing the Atopic March

Eric L. Simpson; Lawrence F. Eichenfield; Charles N. Ellis; Anthony J. Mancini; Amy S. Paller

doi:10.1016/j.sder.2012.08.001

Current Issues in Atopic Comorbidities and Preventing the Atopic March

Eric L. Simpson, Lawrence F. Eichenfield, Charles N. Ellis, Anthony J. Mancini, Amy S. Paller

Dermatology

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Abstract

The individual, family, and public health burden of atopic dermatitis (AD) is considerable. The prevalence of AD is high, the signs and symptoms of the disease adversely affect quality of life for patients and their families, and the comorbid conditions associated with AD can increase considerably the negative impact of the disease. These comorbid conditions patients with AD are susceptible to include skin infectious, IgE-mediated diseases, and mental health disorders. New research identifies the skin barrier as not only an important initiator of atopic dermatitis but may even be a site for allergic sensitization to protein antigens. The skin barrier represents a potential new target for novel atopic prevention strategies.

Original language	English (US)
Pages (from-to)	S6-S9
Journal	Seminars in cutaneous medicine and surgery
Volume	31
Issue number	3 SUPPL.
DOIs	https://doi.org/10.1016/j.sder.2012.08.001
State	Published - Sep 2012

Keywords

Atopic dermatitis
Atopic dermatitis comorbidities
IgE sensitization
Transcutaneous

ASJC Scopus subject areas

Surgery
Dermatology

Access to Document

10.1016/j.sder.2012.08.001

Cite this

@article{cff4c7e298e643f090d96b3b34b796b3,

title = "Current Issues in Atopic Comorbidities and Preventing the Atopic March",

abstract = "The individual, family, and public health burden of atopic dermatitis (AD) is considerable. The prevalence of AD is high, the signs and symptoms of the disease adversely affect quality of life for patients and their families, and the comorbid conditions associated with AD can increase considerably the negative impact of the disease. These comorbid conditions patients with AD are susceptible to include skin infectious, IgE-mediated diseases, and mental health disorders. New research identifies the skin barrier as not only an important initiator of atopic dermatitis but may even be a site for allergic sensitization to protein antigens. The skin barrier represents a potential new target for novel atopic prevention strategies.",

keywords = "Atopic dermatitis, Atopic dermatitis comorbidities, IgE sensitization, Transcutaneous",

author = "Simpson, {Eric L.} and Eichenfield, {Lawrence F.} and Ellis, {Charles N.} and Mancini, {Anthony J.} and Paller, {Amy S.}",

year = "2012",

month = sep,

doi = "10.1016/j.sder.2012.08.001",

language = "English (US)",

volume = "31",

pages = "S6--S9",

journal = "Seminars in cutaneous medicine and surgery",

issn = "1085-5629",

publisher = "W.B. Saunders Ltd",

number = "3 SUPPL.",

}

TY - JOUR

T1 - Current Issues in Atopic Comorbidities and Preventing the Atopic March

AU - Simpson, Eric L.

AU - Eichenfield, Lawrence F.

AU - Ellis, Charles N.

AU - Mancini, Anthony J.

AU - Paller, Amy S.

PY - 2012/9

Y1 - 2012/9

N2 - The individual, family, and public health burden of atopic dermatitis (AD) is considerable. The prevalence of AD is high, the signs and symptoms of the disease adversely affect quality of life for patients and their families, and the comorbid conditions associated with AD can increase considerably the negative impact of the disease. These comorbid conditions patients with AD are susceptible to include skin infectious, IgE-mediated diseases, and mental health disorders. New research identifies the skin barrier as not only an important initiator of atopic dermatitis but may even be a site for allergic sensitization to protein antigens. The skin barrier represents a potential new target for novel atopic prevention strategies.

AB - The individual, family, and public health burden of atopic dermatitis (AD) is considerable. The prevalence of AD is high, the signs and symptoms of the disease adversely affect quality of life for patients and their families, and the comorbid conditions associated with AD can increase considerably the negative impact of the disease. These comorbid conditions patients with AD are susceptible to include skin infectious, IgE-mediated diseases, and mental health disorders. New research identifies the skin barrier as not only an important initiator of atopic dermatitis but may even be a site for allergic sensitization to protein antigens. The skin barrier represents a potential new target for novel atopic prevention strategies.

KW - Atopic dermatitis

KW - Atopic dermatitis comorbidities

KW - IgE sensitization

KW - Transcutaneous

UR - http://www.scopus.com/inward/record.url?scp=84866883929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866883929&partnerID=8YFLogxK

U2 - 10.1016/j.sder.2012.08.001

DO - 10.1016/j.sder.2012.08.001

M3 - Article

C2 - 23021784

AN - SCOPUS:84866883929

SN - 1085-5629

VL - 31

SP - S6-S9

JO - Seminars in cutaneous medicine and surgery

JF - Seminars in cutaneous medicine and surgery

IS - 3 SUPPL.

ER -

Current Issues in Atopic Comorbidities and Preventing the Atopic March

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this